Xie Guozhu et al. [23] reported that radiotherapy could enrich tumor stem cells, and BCSCs mediated Her2 subtype transformation and Her2-negative BC cell radioresistance, enhancing radioresistance and aggressivity. Here, ERBB2 is linked to breast cancer.